Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Pre-close Trading Statement

25 Jan 2018 07:00

RNS Number : 8506C
Biome Technologies PLC
25 January 2018
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")

 

 

25 January 2018

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Pre-close Trading Statement

 

 

Biome Technologies plc's pre-close trading statement for the financial year ended 31 December 2017 is set out below.

 

Group revenues for the year were £6.2m, 36% ahead of the 2016 revenues of £4.6m.

 

Revenues in the Bioplastics division were £2.3m, an increase of 44% on 2016 revenues of £1.6m. The Bioplastics division benefitted from an increase in the use of its material for the coffee market following the commercialisation of the innovative BiomeMesh filter material. The shifting perception of plastic waste both in public opinion and amongst policy-makers, particularly in the UK, provides encouragement for future growth in the use of bioplastic products.

 

The RF division also had a strong year with revenues of £4.0m, an increase of 32% over 2016 revenues of £3.0m. The increase in revenues is attributable mainly to robust demand for the fibre optic furnace products underpinned by the roll out of infrastructure investment in telecommunications, including "5G", in Asia. As 2018 commences, the RF division has a strong order book which is ahead of that at the comparable point in 2017.

 

The Group's cash position at 31 December 2017 was £2.3m (30 September 2017: £2.4m; 31 December 2016: £1.5m). The increase in cash year on year is a mixture of trading performance, working capital movements and the £0.45m received under the previously reported settlement agreement.

 

The Board expects that the Group will record a small profit before interest, tax, depreciation, amortisation, and share option charges ("EBITDA") for the 2017 financial year (2016: trading EBITDA loss of £0.2m excluding the settlement agreement).

 

The audited results for the year ended 31 December 2017 are scheduled to be published on 27 March 2018.

 

 

-Ends-

 

 

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDZLFLVFFXBBQ
Date   Source Headline
3rd Sep 20127:00 amRNSInterim Results
29th Aug 20127:00 amRNSPrototype Delivery for Stanelco RF Technologies
19th Jul 20127:00 amRNSInterim Trading Statement
17th Jul 20127:00 amRNSFinancing and Loan Repayment
12th Jul 20127:00 amRNSPatent Litigation Update
10th Jul 20124:40 pmRNSSecond Price Monitoring Extn
10th Jul 20124:35 pmRNSPrice Monitoring Extension
19th Jun 20127:00 amRNSLoan Facility Extension/Directorate Change
31st May 20127:00 amRNSTrading Update
15th May 20124:40 pmRNSSecond Price Monitoring Extn
15th May 20124:35 pmRNSPrice Monitoring Extension
25th Apr 20121:35 pmRNSResult of AGM
25th Apr 20127:00 amRNSTrading Update
4th Apr 20127:00 amRNSNotification of Award under the Public Equity Plan
29th Mar 20127:00 amRNSPreliminary Results
19th Jan 20127:00 amRNSPre-close Trading Statement
10th Jan 20127:00 amRNSContract for RF Technologies Business
16th Dec 20111:27 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSLoan Reclassification
4th Nov 20117:00 amRNSTrading Update
21st Oct 20114:35 pmRNSPrice Monitoring Extension
19th Sep 20117:00 amRNSSector Reclassification
1st Sep 20117:01 amRNSDirectorate Changes
1st Sep 20117:00 amRNSInterim Results
16th May 201111:07 amRNSDirector/PDMR Shareholding
9th May 20117:00 amRNSDirector/PDMR Shareholding
5th May 20112:28 pmRNSResult of AGM
5th May 20117:00 amRNSTrading Update
12th Apr 201112:22 pmRNSHolding(s) in Company
28th Mar 20114:23 pmRNSAnnual Report &Accounts for 2010 and Notice of AGM
24th Mar 20117:00 amRNSPreliminary Results
28th Feb 201112:22 pmRNSTotal Voting Rights
23rd Feb 20114:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20114:35 pmRNSPrice Monitoring Extension
17th Feb 20117:00 amRNSAppointment of Nominated Adviser & Joint Brokers
5th Nov 20107:00 amRNSTrading Update
14th Oct 20107:00 amRNSDirector/PDMR Shareholding
7th Oct 20107:00 amRNSDirectorate Change
5th Oct 20107:00 amRNSNotification of Awards under Public Equity Plan
17th Sep 20104:37 pmRNSPrice Monitoring Extension
27th Aug 20107:00 amRNSHalf Yearly Report
13th Jul 20107:55 amRNSFirst Day of Dealings on AIM
12th Jul 20107:00 amRNSChange of Name
1st Jul 201010:07 amRNSTotal Voting Rights
22nd Jun 20101:07 pmRNSResult of AGM
22nd Jun 20107:00 amRNSAnnual General Meeting & Trading Update
21st Jun 20104:41 pmRNSSch 1 update - Stanelco plc
21st Jun 20104:15 pmRNSDirector/PDMR Shareholding: Correction
15th Jun 20105:03 pmRNSDirector/PDMR Shareholding
14th Jun 201012:40 pmRNSSchedule 1 - Stanelco PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.